Showing results (41-50 of 361) with videos related to
Sort By:
Pageof 37
Journal of Hepatocellular Carcinoma|June 9, 2021
Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular CarcinomaCecilia Monge, Changqing Xie, Seth M Steinberg, et al.Hepatology (Baltimore, Md.)|May 15, 2016
The case for immune-based approaches in biliary tract carcinomaAustin G Duffy, Oxana V Makarova-Rusher, Tim F GretenSeminars in Immunology|March 12, 2026
Chimeric antigen receptor therapy for hepatocellular carcinomaLorenz Kocheise, Mohamed-Reda Benmebarek, Mitchell Ho, et al.JCO Global Oncology|March 13, 2025
Disparities in Cholangiocarcinoma Research and Trials: Challenges and Opportunities in the United StatesOyepeju F Abioye, Rebekah Kaufman, Tim F Greten, et al.Digestive Diseases (Basel, Switzerland)|May 13, 2010
Immune responses in hepatocellular carcinomaFirouzeh Korangy, Bastian Höchst, Michael P Manns, et al.Expert Review of Gastroenterology & Hepatology|June 10, 2010
Immunotherapy of hepatocellular carcinomaFirouzeh Korangy, Bastian Höchst, Michael P Manns, et al.Cell|June 9, 2023
Medication effects on the gut microbiome in allo-HCTWelles Robinson, E Michael Gertz, Tim F Greten, et al.STAR Protocols|May 20, 2021
Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production in vivo and in vitroSimon Wabitsch, Justin D McCallen, Chi Ma, et al.Pancreas|May 24, 2016
Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and OutcomesOxana V Makarova-Rusher, Susanna Ulahannan, Tim F Greten, et al.Journal of Hepatocellular Carcinoma|August 3, 2023
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United StatesCecilia Monge, J Alberto Maldonado, Katherine A McGlynn, et al.Pageof 37